Lipedema medical research and regulation

Lipedema is increasingly recognized as a complex systemic condition involving the connective tissue, microcirculation, lymphatic, and venous systems. Characterized by symmetrical fat accumulation primarily in the lower limbs, the condition is a genetic pathology affecting women and is often misdiagnosed as obesity or lymphedema. It is estimated to affect approximately one in nine women globally.

Clinical research, specifically the multicenter LIPLEG study published in The Lancet, has indicated that liposuction provides significantly greater pain reduction and improved quality of life for patients compared to conservative therapy. While the study noted more frequent adverse events in the surgical group, 68.3% of operated patients achieved clinically relevant pain reduction.

In Germany, new regulatory changes by the Federal Joint Committee (G-BA) have introduced a ‘four-eyes principle’ for treating lipohyperplasia dolorosa (LiDo). This regulation mandates a separation of roles, prohibiting specialists in plastic, reconstructive, and aesthetic surgery from providing the initial diagnosis if they are also the performing surgeon.